Use of Therapeutics Associated With Reductions in Mortality and Hospitalization in Patients Infected With Omicron Variant
Ritonavir-boosted nirmatrelvir and molnupiravir are currently used in the U.S. and in other countries to treat non-hospitalized patients who have mild-to-moderate COVID-19 and who are at high risk for progression…